Life Science Specialist - @4BIOCapital (Views are my own)
Joined February 2017
- Tweets 424
- Following 1,089
- Followers 245
- Likes 675
70 Photos and videos
24 Jun 2024
Nice data. Another step forward for RNAi medicine, congrats @alnylam! #AdvancedTherapies
24 Jun 2024
We are pleased to share positive topline results from our HELIOS-B Phase 3 study of vutrisiran, an investigational #RNAi therapeutic in development for the treatment of #ATTR #amyloidosis w/ cardiomyopathy. Read the press release: bit.ly/3VwvRtY #RNAiTherapeutics #siRNA
84
I recommend watching the full run of play leading up to this and following Palhinha as the ball goes from one side the pitch to the other and then he sees the danger and sprints for it.
Almost expecting David Attenborough to be doing voice over as the prey looked for its target.
4
8
78
34,385
1 Sep 2023
“The story of Fulham cannot be told without a chapter on the positive impact of Mr Al Fayed as Chairman.”
Truth. 🤍🖤 #ffc
Thank you Mr Al Fayed. ❤️
2
414
31 Aug 2023
Congrats @BoisselStephane & the whole @SparingVision team. Another step forward on the mission to deliver options to patient with ocular disorders, for whom there are no options! #GeneTherapy #Fierce23
31 Aug 2023
✨ Shining bright in the heart of Times Square! ✨
In recognition of being named a 'Fierce 15' company for 2023, @Nasdaq showcased this milestone on the big screen in New York. 🍎
More here: sparingvision.com/sparingvis…
#Fierce23 #BeFierce #GenomicMedicines #GeneTherapy
3
187
Owen retweeted
31 Aug 2023
✨ Shining bright in the heart of Times Square! ✨
In recognition of being named a 'Fierce 15' company for 2023, @Nasdaq showcased this milestone on the big screen in New York. 🍎
More here: sparingvision.com/sparingvis…
#Fierce23 #BeFierce #GenomicMedicines #GeneTherapy
1
5
466
Owen retweeted
18 Aug 2023
At Entact, we’re aiming to do an entirely new thing: create medicines that enhance, rather than inhibit, the function of key proteins by harnessing the power of DUBs.
Learn more about this approach from David Komander and our other scientific founders: ow.ly/JNaI50PAzqh
1
2
174
Owen retweeted
16 Aug 2023
Our gene-independent gene therapy product SPVN20 targets retinitis pigmentosa (RP) as the first indication 👀 Let’s take a closer look…
sparingvision.com/spvn20_30/
1
4
7
446
14 Aug 2023
August in biotech venture usually sees a lull. Not this year. 🚀 Fewer OOOs, more activity, especially from the UK & Europe. Sign of tighter capital or just more due-diligence time? Thoughts? 🤔 #Biotech #VentureCapital #UKBiotech #EuropeanBiotech"
36
Owen retweeted
25 Jul 2023
ICYMI, our SVP of Molecular Discovery Simon Bushell shared the invaluable leadership strategies he’s used to build a thriving R&D team here at Entact Bio.
4️⃣ Essential Team Traits
4️⃣ Ways to Foster a Team
Check out his #biotech #teambuilding insights 👇
linkedin.com/pulse/how-build…
1
2
102
Owen retweeted
27 Jun 2023
We are excited to kick off Entact's #EmployeeSpotlight series by highlighting Elma Kadic, an Associate Director in our Biological Sciences division. Throughout her career, Elma has identified powerful new technologies and applied them across the drug-discovery continuum.
1
1
3
147
21 Jun 2023
Excited to be in Paris for a @sparingvision board meeting this week! A privilege to spend time with such an amazing team with brilliant minds using cutting-edge science to create a brighter future for ocular health. #SparingVision #Biotech #GeneTherapy
2
53
16 May 2023
Great to see @4biocapital portfolio company, Ray Therapeutics, $100m Series A covered today In the WSJ alongside another, SparingVision, who are now enrolling patients in their clinical study of SPVN06! #GeneTherapy #ASGCT
16 May 2023
Ray Therapeutics has just landed $100 million to attack retinitis pigmentosa, with a focus on people who have lost their vision. on.wsj.com/3Wep08A
4
209
16 May 2023
Excited to be heading to #ASGCT this week. A few days out of the trenches and taking in the plus from across the sector and sharing portfolio company updates!
1
102
3 Feb 2023
In the @PharmaScripAsks Series Part 5 I spoke about innovation in manufacturing and delivery, and what I expect to see in 2023. Read the full article here: bit.ly/3wMtY0e #Fund #Biopharma #Manufacturing #Therapies #innovation
2
61
3 Feb 2023
This week I presented at @LINKJEN3’s Advanced Therapy Showcase in Tokyo#3 (ATST#3). It was a pleasure to be invited to present once again and I am proud to have participated since the first #ATST 3 years ago. More: bit.ly/3JzuXZk
3
69
13 Jan 2023
Just wrapped up a fantastic JPMorgan conference in SF! Great insights, engaging discussions, and valuable networking opportunities. #JPMorgan #SanFrancisco #Biotech #JPM2023
2
166